XML 31 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities      
Net income (loss) $ 99,189 $ 67,808 $ (345,582)
Adjustments to reconcile net income (loss) to cash provided by operating activities      
Stock-based compensation 142,718 143,352 122,210
Amortization of deferred commissions 62,269 59,461 53,471
Amortization of intangible assets and depreciation 17,585 18,746 18,780
Amortization of right-of-use lease assets 17,842 15,912 15,940
Foreign currency transaction loss (gain) 912 5,242 (4,560)
Loss on capped call transactions 663 1,348 57,382
Deferred income taxes (1,544) 363 168,890
(Accretion) amortization of investments (15,263) (3,302) 1,972
(Gain) on investments (869) (10,841) (6,578)
(Gain) on repurchases of convertible senior notes (459) (7,855) 0
Other non-cash 3,728 5,557 4,763
Change in operating assets and liabilities:      
Accounts receivable, unbilled receivables, and contract assets 79,034 (57,602) (51,157)
Other current assets (50,005) 11,360 (9,133)
Other current liabilities (7,115) (8,777) 529
Deferred revenue 48,360 45,123 62,578
Deferred commissions (57,628) (44,529) (53,857)
Other long-term assets and liabilities 6,509 (23,581) (13,312)
Cash provided by operating activities 345,926 217,785 22,336
Investing activities      
Purchases of investments (559,365) (287,287) (41,015)
Proceeds from maturities and called investments 364,501 242,593 66,583
Sales of investments 0 10,725 23,808
Payments for acquisitions, net of cash acquired 0 0 (922)
Investment in property and equipment (7,712) (16,781) (35,379)
Cash (used in) provided by investing activities (202,576) (50,750) 13,075
Financing activities      
Repurchases of convertible senior notes (33,890) (88,989) 0
Dividend payments to stockholders (10,199) (9,964) (9,834)
Proceeds from employee stock purchase plan 6,709 7,744 9,172
Proceeds from stock option exercises 80,651 10,821 0
Common stock repurchases for tax withholdings for net settlement of equity awards (5,435) (1,916) (20,620)
Common stock repurchases under stock repurchase program (68,057) 0 (25,707)
Other 7 341 0
Cash (used in) financing activities (30,214) (81,963) (46,989)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (4,434) 2,701 (3,333)
Net increase (decrease) in cash, cash equivalents and restricted cash 108,702 87,773 (14,911)
Cash, cash equivalents, and restricted cash, beginning of period 232,827 145,054 159,965
Cash, cash equivalents, and restricted cash, end of period 341,529 232,827 145,054
Cash and cash equivalents 337,103 229,902 145,054
Restricted cash included in other current assets 98 0 0
Restricted cash included in other long-term assets 4,328 2,925 0
Total cash, cash equivalents and restricted cash 341,529 232,827 145,054
Supplemental disclosures      
Interest paid on convertible notes 3,810 4,134 4,500
Income taxes paid 82,317 11,664 7,645
Non-cash investing and financing activity:      
Investment in property and equipment included in accounts payable and accrued liabilities 1,723 66 9,914
Dividends payable $ 2,583 $ 2,515 $ 2,474